AU2305092A - Methods and compositions for treating pulmonary and cardiac disorders using optically pure (+) pirbuterol - Google Patents

Methods and compositions for treating pulmonary and cardiac disorders using optically pure (+) pirbuterol

Info

Publication number
AU2305092A
AU2305092A AU23050/92A AU2305092A AU2305092A AU 2305092 A AU2305092 A AU 2305092A AU 23050/92 A AU23050/92 A AU 23050/92A AU 2305092 A AU2305092 A AU 2305092A AU 2305092 A AU2305092 A AU 2305092A
Authority
AU
Australia
Prior art keywords
pirbuterol
compositions
methods
optically pure
treating pulmonary
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU23050/92A
Inventor
James W. Young
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sunovion Pharmaceuticals Inc
Original Assignee
Sepracor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sepracor Inc filed Critical Sepracor Inc
Publication of AU2305092A publication Critical patent/AU2305092A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU23050/92A 1991-06-26 1992-06-25 Methods and compositions for treating pulmonary and cardiac disorders using optically pure (+) pirbuterol Abandoned AU2305092A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72172291A 1991-06-26 1991-06-26
US721722 2000-11-27

Publications (1)

Publication Number Publication Date
AU2305092A true AU2305092A (en) 1993-01-25

Family

ID=24899033

Family Applications (1)

Application Number Title Priority Date Filing Date
AU23050/92A Abandoned AU2305092A (en) 1991-06-26 1992-06-25 Methods and compositions for treating pulmonary and cardiac disorders using optically pure (+) pirbuterol

Country Status (2)

Country Link
AU (1) AU2305092A (en)
WO (1) WO1993000090A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3700681A (en) * 1971-02-16 1972-10-24 Pfizer 2-hydroxymethyl-3-hydroxy-6-(1-hydroxy-2-aminoethyl)pyridines
US4812455A (en) * 1984-10-11 1989-03-14 Pfizer Inc. Antiinflammatory compositions and methods

Also Published As

Publication number Publication date
WO1993000090A1 (en) 1993-01-07

Similar Documents

Publication Publication Date Title
AU6904498A (en) Methods and compositions for treating gastric disorders using optically pure (-) pantoprazole
AU7039896A (en) Methods and compositions for treating emesis, nausa and other disorders using optically pure R(+) ondansetron
AU6905391A (en) Methods and compositions for the treatment of hodgkin's disease
AU1453488A (en) Novel compositions for therapeutic percutaneous embolization and the use thereof
HK1012489A1 (en) Composition for revitalizing scar tissue
HU900803D0 (en) Synthetical vertebral disk
ZA929155B (en) Wound healing compositions and methods for preparing and using same.
AU2287495A (en) Methods and compositions for treating depression and other disorders using optically pure s(+) fluoxetine
AU2514592A (en) Methods and compositions for modulating g protein action
AU2593988A (en) Thermosetting composition
AU644245B2 (en) Hair treatment composition
EP0708639A4 (en) Methods and compositions for treating depression and other disorders using optically pure (+) sibutramine
AU578567B2 (en) Antifoulant compositions and use thereof
AU4553089A (en) Fabric treatment composition
AU1970592A (en) Method to treat kaposi's sarcoma
AU3245593A (en) Methods and compositions for treating sleep disorders, convulsive seizures, and other disorders using optically pure (+) zopiclone
EP0700292A4 (en) Methods and compositions for treating gastric disorders using optically pure (+) pantoprazole
EP0711159A4 (en) Methods and compositions for treating asthma, atherosclerosis andinflammatory diseases using optically pure (-)-zileuton
AU1658992A (en) Methods and compositions for treating pulmonary disorders using optically pure terbutaline
AU2305092A (en) Methods and compositions for treating pulmonary and cardiac disorders using optically pure (+) pirbuterol
AU2270092A (en) Methods and compositions for treating pulmonary and cardiac disorders using optically pure (-)pirbuterol
AU9159891A (en) Compositions and methods for achieving improved physiological response to exercice
AU590952B2 (en) Photosensitizers and polymerizable compositions
AU3084992A (en) 1,4-dihydropyridines for use in the treatment of dermatosis
GB9100970D0 (en) Acne treatment composition